"Scalded mouth" caused by angiotensin-converting-enzyme inhibitors.
作者信息
Vlasses P H, Rotmensch H H, Ferguson R K, Sheaffer S L
出版信息
Br Med J (Clin Res Ed). 1982 Jun 5;284(6330):1672-3. doi: 10.1136/bmj.284.6330.1672.
Abstract
摘要
相似文献
1
"Scalded mouth" caused by angiotensin-converting-enzyme inhibitors.血管紧张素转换酶抑制剂引起的“口腔烫伤”
Br Med J (Clin Res Ed). 1982 Jun 5;284(6330):1672-3. doi: 10.1136/bmj.284.6330.1672.
2
Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.卡托普利和依那普利：血管紧张素转换酶（ACE）抑制剂。
Ration Drug Ther. 1984 Mar;18(3):1-5.
3
Enalapril, a rash, and captopril.依那普利、皮疹和卡托普利。
Ann Intern Med. 1984 Apr;100(4):616. doi: 10.7326/0003-4819-100-4-616_1.
4
Captopril and enalapril.卡托普利和依那普利。
Ann Intern Med. 1983 Aug;99(2):281. doi: 10.7326/0003-4819-99-2-281_1.
5
Safety of angiotensin-converting-enzyme inhibitors.血管紧张素转换酶抑制剂的安全性。
Lancet. 1985 Apr 6;1(8432):820. doi: 10.1016/s0140-6736(85)91479-5.
6
Safety of angiotensin-converting-enzyme inhibitors.血管紧张素转换酶抑制剂的安全性。
Lancet. 1985 Mar 9;1(8428):580-1. doi: 10.1016/s0140-6736(85)91239-5.
7
Captopril and enalapril.
Ann Intern Med. 1983 Apr;98(4):556-7. doi: 10.7326/0003-4819-98-4-556_2.
8
Relative safety of angiotensin-converting-enzyme inhibitors.血管紧张素转换酶抑制剂的相对安全性。
Lancet. 1985 Jun 8;1(8441):1344. doi: 10.1016/s0140-6736(85)92847-8.
9
Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics.血管紧张素转换酶抑制剂与利尿剂联合使用时的肾功能不全。
Br Med J (Clin Res Ed). 1984 Mar 17;288(6420):844-5. doi: 10.1136/bmj.288.6420.844.
10
Angiotensin-converting enzyme inhibitors: past, present, and bright future.血管紧张素转换酶抑制剂：过去、现在与光明未来。
Lancet. 1985 Jan 5;1(8419):30-4. doi: 10.1016/s0140-6736(85)90975-4.
引用本文的文献
1
Drug-induced Tongue Disorders: A Comprehensive Literature Review.药物性舌部疾病：一篇综合文献综述
Curr Drug Saf. 2025;20(2):148-213. doi: 10.2174/0115748863299971240513061630.
2
Selecting appropriate antihypertensive drug dosages.选择合适的抗高血压药物剂量。
Drugs. 1994 Apr;47(4):567-75. doi: 10.2165/00003495-199447040-00001.
3
Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.依那普利。对其药效学和药代动力学特性以及在高血压和充血性心力衰竭中的治疗用途的综述。
Drugs. 1986 Mar;31(3):198-248. doi: 10.2165/00003495-198631030-00002.
4
Enalapril: a review of human pharmacology.依那普利：人体药理学综述。
Drugs. 1985;30 Suppl 1:13-24. doi: 10.2165/00003495-198500301-00004.
本文引用的文献
1
Ulceration of the tongue: a complication of captopril therapy.舌溃疡：卡托普利治疗的一种并发症。
Ann Intern Med. 1981 May;94(5):659. doi: 10.7326/0003-4819-94-5-659.
2
Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captopril.
Am Heart J. 1981 May;101(5):650-6. doi: 10.1016/0002-8703(81)90233-7.
3
Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421".
Lancet. 1981 Sep 12;2(8246):543-7. doi: 10.1016/s0140-6736(81)90937-5.
4
Aphthous ulcers of mouth from captopril.卡托普利引起的口腔阿弗他溃疡。
Lancet. 1979 Dec 15;2(8155):1297-8. doi: 10.1016/s0140-6736(79)92304-3.
5
Temporary ageusia related to captopril.与卡托普利相关的暂时性味觉丧失。
Lancet. 1979 Sep 8;2(8141):526. doi: 10.1016/s0140-6736(79)91579-4.
Zotero 插件